Does ADALIMUMAB Cause Blood creatine phosphokinase increased? 159 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Blood creatine phosphokinase increased have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
159
Reports of Blood creatine phosphokinase increased with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
6
Deaths
86
Hospitalizations
How Dangerous Is Blood creatine phosphokinase increased From ADALIMUMAB?
Of the 159 reports, 6 (3.8%) resulted in death, 86 (54.1%) required hospitalization, and 7 (4.4%) were considered life-threatening.
Is Blood creatine phosphokinase increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Blood creatine phosphokinase increased?
ATORVASTATIN (1,491)
SIMVASTATIN (895)
ROSUVASTATIN (859)
QUETIAPINE (663)
CLOZAPINE (610)
ARIPIPRAZOLE (594)
OLANZAPINE (561)
DAPTOMYCIN (461)
RISPERIDONE (402)
EZETIMIBE (350)
Which ADALIMUMAB Alternatives Have Lower Blood creatine phosphokinase increased Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB